Drug intelligence / Profile preview

1(R)-1-acetamido-2-(3-carboxyphenyl)ethyl boronic acid

Development stage
Preclinical
Modality
Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
01

Overview

1(R)-1-acetamido-2-(3-carboxyphenyl)ethyl boronic acid is a synthetic small molecule and organoboron compound. It is structurally characterized by an acetamido group, a carboxy-substituted phenyl ring, and a boronic acid moiety. This compound has been studied primarily as an experimental inhibitor of β-lactamase enzymes, particularly TEM-type β-lactamases in bacteria. By mimicking the transition state of the enzyme's natural substrate, it acts as a competitive inhibitor at the active site of β-lactamase, potentially restoring the efficacy of β-lactam antibiotics against resistant bacterial strains[5][7]. The compound remains experimental with no approved clinical indications.

Other names
3-[(2R)-2-acetamido-2-(dihydroxyboryl)ethyl]benzoic acidBenzoic acid, 3-[(2R)-2-(acetylamino)-2-boronoethyl]-Acide 3-[(2R)-2-acétamido-2-(dihydroxyboryl)éthyl]benzoïque (French)
02

Targets

CD248 (Endosialin)

Beyond the preview

Go deeper on 1(R)-1-acetamido-2-(3-carboxyphenyl)ethyl boronic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1(R)-1-acetamido-2-(3-carboxyphenyl)ethyl boronic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call